Cargando…

Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients

The exceptional outbreak of COVID-19 pandemic has let the scientific community to work closely and quickly learnt things in a very short period of time. This has let us recognize that thromboembolic complications are responsible for morbidity and mortality among the COVID-19 infected patients. Avail...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Syed Imran, Khan, Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mosby-Year Book 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320667/
https://www.ncbi.nlm.nih.gov/pubmed/32703535
http://dx.doi.org/10.1016/j.cpcardiol.2020.100648
_version_ 1783551288953274368
author Ahmed, Syed Imran
Khan, Shahzad
author_facet Ahmed, Syed Imran
Khan, Shahzad
author_sort Ahmed, Syed Imran
collection PubMed
description The exceptional outbreak of COVID-19 pandemic has let the scientific community to work closely and quickly learnt things in a very short period of time. This has let us recognize that thromboembolic complications are responsible for morbidity and mortality among the COVID-19 infected patients. Available data have suggested a possible multifactorial basis of these complications, and while efforts are being made to treat this infection, preventive measures with the use of systemic anticoagulation were quickly adopted to deal with this issue. Despite obvious benefits as appeared with the use of systemic anticoagulation, most of the emerged data were retrospective, hence raise questions on the possible interplay of the confounders as well as long-term benefits and safety of systemic anticoagulation.
format Online
Article
Text
id pubmed-7320667
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mosby-Year Book
record_format MEDLINE/PubMed
spelling pubmed-73206672020-06-29 Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients Ahmed, Syed Imran Khan, Shahzad Curr Probl Cardiol Article The exceptional outbreak of COVID-19 pandemic has let the scientific community to work closely and quickly learnt things in a very short period of time. This has let us recognize that thromboembolic complications are responsible for morbidity and mortality among the COVID-19 infected patients. Available data have suggested a possible multifactorial basis of these complications, and while efforts are being made to treat this infection, preventive measures with the use of systemic anticoagulation were quickly adopted to deal with this issue. Despite obvious benefits as appeared with the use of systemic anticoagulation, most of the emerged data were retrospective, hence raise questions on the possible interplay of the confounders as well as long-term benefits and safety of systemic anticoagulation. Mosby-Year Book 2020-09 2020-06-27 /pmc/articles/PMC7320667/ /pubmed/32703535 http://dx.doi.org/10.1016/j.cpcardiol.2020.100648 Text en . Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ahmed, Syed Imran
Khan, Shahzad
Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients
title Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients
title_full Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients
title_fullStr Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients
title_full_unstemmed Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients
title_short Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients
title_sort coagulopathy and plausible benefits of anticoagulation among covid-19 patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320667/
https://www.ncbi.nlm.nih.gov/pubmed/32703535
http://dx.doi.org/10.1016/j.cpcardiol.2020.100648
work_keys_str_mv AT ahmedsyedimran coagulopathyandplausiblebenefitsofanticoagulationamongcovid19patients
AT khanshahzad coagulopathyandplausiblebenefitsofanticoagulationamongcovid19patients